| Dr Peter J Chandler, MD | |
|
8716 E Mill Plain Blvd, Vancouver, WA 98664 | |
| (360) 256-2000 | |
| (360) 514-7553 |
| Full Name | Dr Peter J Chandler |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 8716 E Mill Plain Blvd, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477594406 | NPI | - | NPPES |
| 8287716 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD00040404 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Soledad Community Health Care District | 4385635085 | 9 |
News Archive
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.
With finals season in full swing this month, weary students are looking for anything that can help them endure late-night study sessions. Energy drink companies, whose products are already popular on college campuses, are increasingly looking to replace coffee as a student's go-to answer for a stamina boost during finals - and then for late nights after graduation.
› Verified 4 days ago
| Entity Name | Southern Monterey County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114917564 PECOS PAC ID: 7719883461 Enrollment ID: O20050216000803 |
News Archive
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.
With finals season in full swing this month, weary students are looking for anything that can help them endure late-night study sessions. Energy drink companies, whose products are already popular on college campuses, are increasingly looking to replace coffee as a student's go-to answer for a stamina boost during finals - and then for late nights after graduation.
› Verified 4 days ago
| Entity Name | County Of Monterey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205863255 PECOS PAC ID: 2466345632 Enrollment ID: O20050502000456 |
News Archive
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.
With finals season in full swing this month, weary students are looking for anything that can help them endure late-night study sessions. Energy drink companies, whose products are already popular on college campuses, are increasingly looking to replace coffee as a student's go-to answer for a stamina boost during finals - and then for late nights after graduation.
› Verified 4 days ago
| Entity Name | County Of Monterey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457303356 PECOS PAC ID: 2466345632 Enrollment ID: O20050712001287 |
News Archive
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.
With finals season in full swing this month, weary students are looking for anything that can help them endure late-night study sessions. Energy drink companies, whose products are already popular on college campuses, are increasingly looking to replace coffee as a student's go-to answer for a stamina boost during finals - and then for late nights after graduation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter J Chandler, MD Po Box 1600, Vancouver, WA 98668 Ph: (360) 514-7550 | Dr Peter J Chandler, MD 8716 E Mill Plain Blvd, Vancouver, WA 98664 Ph: (360) 256-2000 |
News Archive
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.
With finals season in full swing this month, weary students are looking for anything that can help them endure late-night study sessions. Energy drink companies, whose products are already popular on college campuses, are increasingly looking to replace coffee as a student's go-to answer for a stamina boost during finals - and then for late nights after graduation.
› Verified 4 days ago
Michelle Hocking De Geest, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 14406 Ne 20th Ave, Vancouver, WA 98686 Phone: 360-571-4244 Fax: 360-571-4246 | |
Richard T Kubiniec, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14508 Ne 20th Ave Ste 300, Vancouver, WA 98686 Phone: 360-892-0208 Fax: 360-892-9081 | |
Anna Kerlin Bell-hibbs, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2525 Ne 139th St Ste 270, Vancouver, WA 98686 Phone: 360-882-2778 Fax: 360-604-1672 | |
Dr. Jennifer Catherine O'connor, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Ne 139th St, Ste 350, Vancouver, WA 98686 Phone: 360-256-4060 Fax: 360-256-0103 | |
Dr. Lissa C Daimaru-enoki, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14406 Ne 20th Ave, Vancouver, WA 98686 Phone: 360-571-4244 Fax: 360-571-4246 | |
Jonathan Erich, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Legacy Salmon Creek Hospital - Family Birth Center, 2211 N.e. 139th Street, Vancouver, WA 98686 Phone: 360-487-4295 | |
Michelle Eston Gruner, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14406 Ne 20th Ave, Vancouver, WA 98686 Phone: 855-285-4246 Fax: 360-571-4246 |